“…However, the potential biohazards of engineered inorganic nanoparticles, including their impact on health and environment, have extensively limited their clinical applications. Therefore, researchers have shifted their focus from inorganic to organic nanomaterials, such as poly(lactic-co-glycolic acid), 10,11 chitosan, 12 polypeptides, 13 liposomes, 14 silk fibroin, 15 lipids, [16][17][18] and carbon-based nanomaterials. 19,20 Recently, carbon nanomaterials including carbon nanotubes, 21 carbon nanohorns (CNHs), 22 carbon nanodiamonds, 23 and graphene (GN) 24 have been studied for applications in drug delivery, owing to their excellent biocompatibility, superhydrophilicity, cell internalization property, enhanced permeability and retention (EPR) effect, and flexibility toward surface modifications.…”